Ticker brief
TBPH
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
7
authors 14d
7
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
· daily mean sentiment, 2026-06-29 → 2026-06-29 · now +0.42 (−1 bearish … +1 bullish)
Who spoke7
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BioStocks | C | -0.39 | 1 | +0.50 |
| @MartyChargin | C | -0.72 | 1 | +0.50 |
| @PersimmonTI | A | -0.32 | 1 | -0.10 |
| @FwdQuarter | C | · | 1 | +0.50 |
| @fwpharma | B | +0.22 | 1 | +0.50 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @BiopharmIQ | B | · | 1 | +0.55 |
Recent signals7of 7 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-29 | @BiopharmIQ | +0.55 | ZYME to acquire TBPH in $17/share all-cash deal valued near $929M plus CVR. | · | tweet ↗ |
| 2026-06-29 | @OpenOutcrier | +0.50 | Theravance Biopharma to be acquired by Zymeworks for $17 per share plus CVR. | · | tweet ↗ |
| 2026-06-29 | @fwpharma | +0.50 | Zymeworks buying Theravance for $929M. | · | tweet ↗ |
| 2026-06-29 | @FwdQuarter | +0.50 | TBPH to be acquired by Zymeworks for $17 cash plus CVR. | · | tweet ↗ |
| 2026-06-29 | @PersimmonTI | -0.10 | Comments on TBPH x ZYME as a take-under with CVR. | · | tweet ↗ |
| 2026-06-29 | @MartyChargin | +0.50 | Theravance agreed to be acquired by Zymeworks for $17 per share in cash. | · | tweet ↗ |
| 2026-06-29 | @BioStocks | +0.50 | ZYME to acquire TBPH for $17 per share. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.